Claros Mortgage Trust Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw $482M in loan and REO resolutions, reducing leverage and increasing liquidity, but book value per share declined to $8.58 due to CECL reserves and REO markdowns. Watchlist loans dropped to $1.1B, and new originations are expected to resume in late 2026 or early 2027.
-
The meeting confirmed a quorum, elected nine directors, ratified the auditor, and approved both executive compensation and an amendment to the Incentive Award Plan. All proposals passed by majority or plurality vote, with final results to be published in a Form 8-K.
-
Reported a GAAP net loss and significant loan resolutions in Q1 2026, with a focus on reducing watchlist and non-accrual loans. Deleveraging efforts and new financing improved the balance sheet, while active sale processes target further portfolio turnover.
Fiscal Year 2025
-
Surpassing its 2025 loan resolution target, the firm resolved $2.5 billion in loans, reduced leverage by $1.7 billion, and refinanced its corporate debt, extending maturity to 2030. Liquidity improved, and the focus remains on portfolio cleanup and asset management amid a gradually recovering real estate market.
-
Surpassed $2.3 billion in loan resolutions year-to-date, improved liquidity to $385 million, and reduced leverage, while focusing on resolving riskier loans and monetizing REO assets. Amended term loan B and made a $150 million repayment to address upcoming maturities.
-
Year-to-date, $1.9B in loan resolutions and $221M liquidity increase were achieved, with watchlist loans down to $2.1B. Portfolio deleveraging and REO strategies advanced, while credit reserves rose amid ongoing market recovery and a focus on term loan maturity.
-
Liquidity and leverage improved through $607M in loan resolutions, with $2B in realizations targeted for the year. Q1 saw a GAAP net loss of $0.56 per share, and portfolio risk was reduced in land, office, and hospitality sectors.
Fiscal Year 2024
-
Q4 2024 saw a net loss and reduced loan portfolio, with strong transaction activity and most loan sales near par. Focus for 2025 is on accelerating loan resolutions, improving liquidity, and deleveraging, while navigating a challenging rate environment.
-
Q3 2024 results showed a net loss and continued portfolio repositioning, with multifamily as the largest exposure and significant loan repayments reducing office and life science risk. Management anticipates increased transaction activity in 2025, with capital allocation focused on maximizing returns through selective REO and loan sales.
-
Q2 2024 saw a GAAP net loss and stable distributable earnings, with a dividend cut to preserve capital for opportunistic investments. Multifamily remains the largest segment, and liquidity is improving as repayments accelerate and risk asset growth slows.
-
Transitional lending focus requires active management amid higher rates and stressed borrowers, with improved visibility into repayments and reduced future funding needs. Liquidity is prioritized for commitments and de-leveraging, while asset resolution strategies balance modifications, sales, and foreclosures.